Evren Technologies

Evren Technologies is an innovator in the field of medical neuromodulation devices, transforming the treatment of post-traumatic stress disorder, acute stress reaction, and acute stress disorder by delivering non-invasive, groundbreaking vagus nerve stimulation (VNS) to the auricular branch of the vagus nerve. Our initial product – the Phoenix®100 system – safely and effectively manages transcutaneous auricular VNS (taVNS) in laboratory, clinical, and unsupervised home environments. The Phoenix 100 will also be the clinical trial device in Evren’s pivotal trial seeking De Novo classification from the U.S. Food and Drug Administration. It will deliver safe and effective taVNS therapy without known adverse side effects. Bioelectronic medicine leverages sophisticated technology to modulate the electrical activity of the body's nervous system and has the potential to complement or even replace pharmaceuticals or other interventions.